kabutan

ZERIA PHARMA, 18% Increase in Ordinary Profit, Record High for The First Time in Two Years, Increased Previous Year's Dividend by 1 Yen, This Fiscal Year to Increase Dividend by 1 Yen

Fri May 8, 2026 4:00 pm JST Earnings

4559 ZERIA PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

ZERIA PHARMACEUTICAL CO.,LTD. <4559> [TSE Prime] announced its financial results after the market closed on May 8th (16:00). The consolidated ordinary profit for the fiscal year ended March 2026 decreased by 14.0% from the previous period to 11.0 billion yen. For the fiscal year ending March 2027, the consolidated ordinary profit is expected to expand to 17.7% to 13.0 billion yenExpected to reach record high profits for the first time in two years. This will be the sixth consecutive term of revenue growth.

At the same time, the company increased the annual dividend for the previous term from 48 yen to 49 yen (compared to 47 yen in the prior term), and has decided to increase the dividend this fiscal year to 50 yen, an increase of 1 yen from the previous fiscal year.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit increased 72.4% from the same period last year, reaching 3.75 billion yen. The operating profit margin drastically improved from 8.7% in the same period last year to 15.2%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 75,725 9,621 8,513 7,731 175.4 44 May 9, 2024 J-GAAP
Mar, 2025 87,311 12,197 12,840 9,936 225.4 47 May 8, 2025 J-GAAP
Mar, 2026 89,159 12,374 11,043 8,454 191.8 49 May 8, 2026 J-GAAP
YoY +2.1% +1.5% -14.0% -14.9% -14.9%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Guidance 90,000 12,000 12,000 9,500 215.5 48 May 8, 2025 J-GAAP
Mar, 2026 Results 89,159 12,374 11,043 8,454 191.8 49 May 8, 2026 J-GAAP
Revision Rate -0.9% +3.1% -8.0% -11.0% -11.0%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 39,960 3,641 2,656 1,737 39.4 24 Nov 5, 2025 J-GAAP
Apr - Sep, 2026 Guidance 45,000 6,000 6,000 4,000 90.8 25 May 8, 2026 J-GAAP
YoY +12.6% +64.8% +125.9% +130.3% +130.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 87,311 12,197 12,840 9,936 225.4 47 May 8, 2025 J-GAAP
Mar, 2026 89,159 12,374 11,043 8,454 191.8 49 May 8, 2026 J-GAAP
Mar, 2027 Guidance 95,000 13,000 13,000 10,000 226.9 50 May 8, 2026 J-GAAP
YoY +6.6% +5.1% +17.7% +18.3% +18.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2025 22,538 1,951 2,179 1,710 38.8 8.7 May 8, 2025 J-GAAP
Apr - Jun, 2025 19,489 1,520 1,662 1,090 24.8 7.8 Aug 5, 2025 J-GAAP
Jul - Sep, 2025 20,471 2,121 994 647 14.7 10.4 Nov 5, 2025 J-GAAP
Oct - Dec, 2025 24,117 4,925 4,630 3,817 86.6 20.4 Feb 5, 2026 J-GAAP
Jan - Mar, 2026 25,082 3,808 3,757 2,900 65.8 15.2 May 8, 2026 J-GAAP
YoY +11.3% +95.2% +72.4% +69.6% +69.6%

Related Articles